Subject
Pharmacology (medical),Pharmacology
Reference151 articles.
1. DNA gyrase inhibitors block development of Bacillus subtilis bacteriophage SPO1;Alonso;J. Virol.,1981
2. Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I;Andoh,1987
3. Potent inhibition of sarcoma virus RNA-directed RNA:DNA duplex synthesis and arrest of ascites murine leukemia and sarcoma in vivo by anthracyclines;Apple;Physiol. Chem. Phys.,1971
4. The integrase family of site-specific recombinases: Regional similarities and global diversity;Argos;EMBO J.,1986
5. Inhibition of herpes simplex virus replication by anthracycline compounds;Ash;Antiviral Res.,1987
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Topoisomerase 1B poisons: Over a half‐century of drug leads, clinical candidates, and serendipitous discoveries;Medicinal Research Reviews;2018-11-19
2. The failure of HAART to cure the HIV-1/AIDS complex. Suggestions to add integrase inhibitors as complementary virostatics, and to replace their continuous long combination applications by short sequences differing by drug rotations.;Biomedicine & Pharmacotherapy;2001-07
3. Why have ten or so nontoxic, retrovirus integrase inhibitors not been made available for aids treatment? a ten-year experiment must liberate them;Biomedicine & Pharmacotherapy;1999-12
4. Stimulation of topoisomerase II-mediated DNA cleavage by an indazole analogue of lucanthone;Biochemical Pharmacology;1999-10
5. Inhibition of DNA topoisomerase II catalytic activity by the antiviral agents 7-chloro-1,3-dihydroxyacridone and 1,3,7-trihydroxyacridone∗∗A preliminary account of this work was presented at the 89th AACR meeting held in New Orleans, LA, March 28-April 1, 1998.;Biochemical Pharmacology;1999-08